Leesa Gentry

Executive Officer at RenovoRx.

Raised on RenovoRx filings

$10M

of $10M offered across 1 Form D filing

Form D filings: 1
Teammates: 7
Last filing: Apr 9, 2026

Company

Biotech · Mountain View, CA

Intra-arterial chemotherapy delivery for pancreatic cancer

Intra-arterial chemotherapy delivery for pancreatic cancer

Investors: 16
Still open: $71

Investors: 16
Sector: Biotech
HQ: Mountain View, CA

RenovoRx filings

RenovoRx Form D filings
Filed	Security	Sold of offered	Filing
Apr 9, 2026	Equity	$10M/ $10M	Form D

EquityFiled Apr 9, 2026Form D
$10M/ $10M

Works with

Also named on RenovoRx filings

Shaun R. BagaiChief Executive Officer and Director, Form D signerForm D signer Robert SpiegelDirector Laurence MartonDirector Kirsten Angela MacfarlaneDirector Una S. RyanDirector Mark VollExecutive Officer Ramtin AgahExecutive Officer